TY - JOUR AU - Dhawan, A. AU - Scott, J. G. AU - Harris, A. L. AU - Buffa, F. M. PY - 2018 DA - 2018// TI - Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors JO - Nat Commun VL - 9 UR - https://doi.org/10.1038/s41467-018-07657-1 DO - 10.1038/s41467-018-07657-1 ID - Dhawan2018 ER - TY - JOUR AU - Slabakova, E. AU - Culig, Z. AU - Remsik, J. AU - Soucek, K. PY - 2018 DA - 2018// TI - Correction alternative mechanisms of miR-34a regulation in cancer JO - Cell Death Dis VL - 9 UR - https://doi.org/10.1038/s41419-018-0833-1 DO - 10.1038/s41419-018-0833-1 ID - Slabakova2018 ER - TY - JOUR AU - Welponer, H. AU - Tsibulak, I. AU - Wieser, V. AU - Degasper, C. AU - Shivalingaiah, G. AU - Wenzel, S. AU - Sprung, S. AU - Marth, C. AU - Hackl, H. AU - Fiegl, H. PY - 2020 DA - 2020// TI - The miR-34 family and its clinical significance in ovarian cancer JO - J Cancer VL - 11 UR - https://doi.org/10.7150/jca.33831 DO - 10.7150/jca.33831 ID - Welponer2020 ER - TY - JOUR AU - Zuo, Y. AU - Zheng, W. AU - Liu, J. AU - Tang, Q. AU - Wang, S. S. AU - Yang, X. S. PY - 2020 DA - 2020// TI - MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells JO - Neoplasma VL - 67 UR - https://doi.org/10.4149/neo_2019_190202N106 DO - 10.4149/neo_2019_190202N106 ID - Zuo2020 ER - TY - JOUR AU - Zhu, M. AU - Wu, J. AU - Ma, X. AU - Huang, C. AU - Wu, R. AU - Zhu, W. AU - Li, X. AU - Liang, Z. AU - Deng, F. AU - Zhu, J. PY - 2019 DA - 2019// TI - Butyl benzyl phthalate promotes prostate cancer cell proliferation through miR-34a downregulation JO - Toxicol in Vitro VL - 54 UR - https://doi.org/10.1016/j.tiv.2018.09.007 DO - 10.1016/j.tiv.2018.09.007 ID - Zhu2019 ER - TY - JOUR AU - Zheng, S. Z. AU - Sun, P. AU - Wang, J. P. AU - Liu, Y. AU - Gong, W. AU - Liu, J. PY - 2019 DA - 2019// TI - MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells JO - World J Gastroenterol VL - 25 UR - https://doi.org/10.3748/wjg.v25.i22.2752 DO - 10.3748/wjg.v25.i22.2752 ID - Zheng2019 ER - TY - JOUR AU - Weng, Y. S. AU - Tseng, H. Y. AU - Chen, Y. A. AU - Shen, P. C. AU - Haq, A. T. AU - Chen, L. M. AU - Tung, Y. C. AU - Hsu, H. L. PY - 2019 DA - 2019// TI - MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer JO - Mol Cancer VL - 18 UR - https://doi.org/10.1186/s12943-019-0988-0 DO - 10.1186/s12943-019-0988-0 ID - Weng2019 ER - TY - JOUR AU - Lopez, C. M. AU - Yu, P. Y. AU - Zhang, X. AU - Yilmaz, A. S. AU - London, C. A. AU - Fenger, J. M. PY - 2018 DA - 2018// TI - MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines JO - PLoS One VL - 13 UR - https://doi.org/10.1371/journal.pone.0190086 DO - 10.1371/journal.pone.0190086 ID - Lopez2018 ER - TY - JOUR AU - Li, Z. AU - Chen, H. PY - 2019 DA - 2019// TI - miR-34a inhibits proliferation, migration and invasion of paediatric neuroblastoma cells via targeting HNF4alpha JO - Artif Cells Nanomed Biotechnol VL - 47 UR - https://doi.org/10.1080/21691401.2019.1637886 DO - 10.1080/21691401.2019.1637886 ID - Li2019 ER - TY - JOUR AU - Kim, J. S. AU - Kim, E. J. AU - Lee, S. AU - Tan, X. AU - Liu, X. AU - Park, S. AU - Kang, K. AU - Yoon, J. S. AU - Ko, Y. H. AU - Kurie, J. M. PY - 2019 DA - 2019// TI - MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas JO - Exp Mol Med VL - 51 ID - Kim2019 ER - TY - JOUR AU - Juracek, J. AU - Stanik, M. AU - Vesela, P. AU - Radova, L. AU - Dolezel, J. AU - Svoboda, M. AU - Slaby, O. PY - 2019 DA - 2019// TI - Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram JO - Urol Oncol VL - 37 UR - https://doi.org/10.1016/j.urolonc.2018.10.014 DO - 10.1016/j.urolonc.2018.10.014 ID - Juracek2019 ER - TY - JOUR AU - Hasakova, K. AU - Reis, R. AU - Vician, M. AU - Zeman, M. AU - Herichova, I. PY - 2019 DA - 2019// TI - Expression of miR-34a-5p is up-regulated in human colorectal cancer and correlates with survival and clock gene PER2 expression JO - PLoS One VL - 14 UR - https://doi.org/10.1371/journal.pone.0224396 DO - 10.1371/journal.pone.0224396 ID - Hasakova2019 ER - TY - JOUR AU - Taylor, A. M. AU - Shih, J. AU - Ha, G. AU - Gao, G. F. AU - Zhang, X. AU - Berger, A. C. AU - Schumacher, S. E. AU - Wang, C. AU - Hu, H. AU - Liu, J. PY - 2018 DA - 2018// TI - Genomic and functional approaches to understanding Cancer aneuploidy JO - Cancer Cell VL - 33 ID - Taylor2018 ER - TY - STD TI - Busch M, Klein S, Grosse-Kreul J, Scheiner O, Metz K, Stephan H, Dunker N. p53, miR-34a and EMP1-newly identified targets of TFF3 signaling in Y79 retinoblastoma cells. Int J Mol Sci. 2019;20. ID - ref14 ER - TY - JOUR AU - Cerna, K. AU - Oppelt, J. AU - Chochola, V. AU - Musilova, K. AU - Seda, V. AU - Pavlasova, G. AU - Radova, L. AU - Arigoni, M. AU - Calogero, R. A. AU - Benes, V. PY - 2019 DA - 2019// TI - MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells JO - Leukemia VL - 33 UR - https://doi.org/10.1038/s41375-018-0230-x DO - 10.1038/s41375-018-0230-x ID - Cerna2019 ER - TY - JOUR AU - Upadhyay, P. AU - Sarker, S. AU - Ghosh, A. AU - Gupta, P. AU - Das, S. AU - Ahir, M. AU - Bhattacharya, S. AU - Chattopadhyay, S. AU - Ghosh, S. AU - Adhikary, A. PY - 2019 DA - 2019// TI - Transferrin-decorated thymoquinone-loaded PEG-PLGA nanoparticles exhibit anticarcinogenic effect in non-small cell lung carcinoma via the modulation of miR-34a and miR-16 JO - Biomater Sci VL - 7 UR - https://doi.org/10.1039/C9BM00912D DO - 10.1039/C9BM00912D ID - Upadhyay2019 ER - TY - JOUR AU - Slabakova, E. AU - Culig, Z. AU - Remsik, J. AU - Soucek, K. PY - 2017 DA - 2017// TI - Alternative mechanisms of miR-34a regulation in cancer JO - Cell Death Dis VL - 8 UR - https://doi.org/10.1038/cddis.2017.495 DO - 10.1038/cddis.2017.495 ID - Slabakova2017 ER - TY - JOUR AU - Jauhari, A. AU - Singh, T. AU - Singh, P. AU - Parmar, D. AU - Yadav, S. PY - 2018 DA - 2018// TI - Regulation of miR-34 family in neuronal development JO - Mol Neurobiol VL - 55 UR - https://doi.org/10.1007/s12035-016-0359-4 DO - 10.1007/s12035-016-0359-4 ID - Jauhari2018 ER - TY - JOUR AU - Siemens, H. AU - Neumann, J. AU - Jackstadt, R. AU - Mansmann, U. AU - Horst, D. AU - Kirchner, T. AU - Hermeking, H. PY - 2013 DA - 2013// TI - Detection of miR-34a promoter methylation in combination with elevated expression of c-met and beta-catenin predicts distant metastasis of colon cancer JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-1703 DO - 10.1158/1078-0432.CCR-12-1703 ID - Siemens2013 ER - TY - JOUR AU - Sullivan, K. D. AU - Galbraith, M. D. AU - Andrysik, Z. AU - Espinosa, J. M. PY - 2018 DA - 2018// TI - Mechanisms of transcriptional regulation by p53 JO - Cell Death Differ VL - 25 UR - https://doi.org/10.1038/cdd.2017.174 DO - 10.1038/cdd.2017.174 ID - Sullivan2018 ER - TY - JOUR AU - Okada, N. AU - Lin, C. P. AU - Ribeiro, M. C. AU - Biton, A. AU - Lai, G. AU - He, X. AU - Bu, P. AU - Vogel, H. AU - Jablons, D. M. AU - Keller, A. C. PY - 2014 DA - 2014// TI - A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression JO - Genes Dev VL - 28 UR - https://doi.org/10.1101/gad.233585.113 DO - 10.1101/gad.233585.113 ID - Okada2014 ER - TY - JOUR AU - Jiang, D. AU - Li, M. AU - Yu, Y. AU - Shi, H. AU - Chen, R. PY - 2019 DA - 2019// TI - microRNA-34a aggravates coxsackievirus B3-induced apoptosis of cardiomyocytes through the SIRT1-p53 pathway JO - J Med Virol VL - 91 UR - https://doi.org/10.1002/jmv.25482 DO - 10.1002/jmv.25482 ID - Jiang2019 ER - TY - JOUR AU - Dai, X. AU - Li, M. AU - Geng, F. PY - 2017 DA - 2017// TI - Omega-3 polyunsaturated fatty acids Eicosapentaenoic acid and Docosahexaenoic acid enhance dexamethasone sensitivity in multiple myeloma cells by the p53/miR-34a/Bcl-2 Axis JO - Biochemistry (Mosc) VL - 82 UR - https://doi.org/10.1134/S0006297917070082 DO - 10.1134/S0006297917070082 ID - Dai2017 ER - TY - JOUR AU - Hart, M. AU - Walch-Ruckheim, B. AU - Krammes, L. AU - Kehl, T. AU - Rheinheimer, S. AU - Tanzer, T. AU - Glombitza, B. AU - Sester, M. AU - Lenhof, H. P. AU - Keller, A. PY - 2019 DA - 2019// TI - miR-34a as hub of T cell regulation networks JO - J Immunother Cancer VL - 7 UR - https://doi.org/10.1186/s40425-019-0670-5 DO - 10.1186/s40425-019-0670-5 ID - Hart2019 ER - TY - JOUR AU - Xiao, X. AU - Gu, Y. AU - Wang, G. AU - Chen, S. PY - 2019 DA - 2019// TI - C-Myc, RMRP, and miR-34a-5p form a positive-feedback loop to regulate cell proliferation and apoptosis in multiple myeloma JO - Int J Biol Macromol VL - 122 UR - https://doi.org/10.1016/j.ijbiomac.2018.10.207 DO - 10.1016/j.ijbiomac.2018.10.207 ID - Xiao2019 ER - TY - JOUR AU - Zhu, J. N. AU - Fu, Y. H. AU - Hu, Z. Q. AU - Li, W. Y. AU - Tang, C. M. AU - Fei, H. W. AU - Yang, H. AU - Lin, Q. X. AU - Gou, D. M. AU - Wu, S. L. PY - 2017 DA - 2017// TI - Activation of miR-34a-5p/Sirt1/p66shc pathway contributes to doxorubicin-induced cardiotoxicity JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-12192-y DO - 10.1038/s41598-017-12192-y ID - Zhu2017 ER - TY - JOUR AU - Momen-Heravi, F. AU - Bala, S. PY - 2018 DA - 2018// TI - Extracellular vesicles in oral squamous carcinoma carry oncogenic miRNA profile and reprogram monocytes via NF-κB pathway JO - Oncotarget VL - 9 UR - https://doi.org/10.18632/oncotarget.26208 DO - 10.18632/oncotarget.26208 ID - Momen-Heravi2018 ER - TY - JOUR AU - Yoon, A. J. AU - Wang, S. AU - Kutler, D. I. AU - Carvajal, R. D. AU - Philipone, E. AU - Wang, T. AU - Peters, S. M. AU - LaRoche, D. AU - Hernandez, B. Y. AU - McDowell, B. D. PY - 2020 DA - 2020// TI - MicroRNA-based risk scoring system to identify early-stage oral squamous cell carcinoma patients at high-risk for cancer-specific mortality JO - Head Neck VL - 42 UR - https://doi.org/10.1002/hed.26089 DO - 10.1002/hed.26089 ID - Yoon2020 ER - TY - JOUR AU - Wang, Y. AU - Chen, J. AU - Chen, X. AU - Jiang, F. AU - Sun, Y. AU - Pan, Y. AU - Zhang, W. AU - Zhang, J. PY - 2017 DA - 2017// TI - MiR-34a suppresses HNSCC growth through modulating cell cycle arrest and senescence JO - Neoplasma VL - 64 UR - https://doi.org/10.4149/neo_2017_408 DO - 10.4149/neo_2017_408 ID - Wang2017 ER - TY - JOUR AU - Hajalirezay Yazdi, S. AU - Paryan, M. AU - Mohammadi-Yeganeh, S. PY - 2018 DA - 2018// TI - An integrated approach of bioinformatic prediction and in vitro analysis identified that miR-34a targets MET and AXL in triple-negative breast cancer JO - Cell Mol Biol Lett VL - 23 UR - https://doi.org/10.1186/s11658-018-0116-y DO - 10.1186/s11658-018-0116-y ID - Hajalirezay Yazdi2018 ER - TY - JOUR AU - Liu, H. AU - Deng, H. AU - Zhao, Y. AU - Li, C. AU - Liang, Y. PY - 2018 DA - 2018// TI - LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling JO - J Exp Clin Cancer Res VL - 37 UR - https://doi.org/10.1186/s13046-018-0950-9 DO - 10.1186/s13046-018-0950-9 ID - Liu2018 ER - TY - JOUR AU - Sun, Z. AU - Zhang, T. AU - Chen, B. PY - 2019 DA - 2019// TI - Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) promotes proliferation and metastasis of osteosarcoma cells by targeting c-met and SOX4 via miR-34a/c-5p and miR-449a/b JO - Med Sci Monit VL - 25 UR - https://doi.org/10.12659/MSM.912703 DO - 10.12659/MSM.912703 ID - Sun2019 ER - TY - JOUR AU - Zhao, M. AU - Wang, Y. AU - Liu, Y. AU - Zhang, W. AU - Liu, Y. AU - Yang, X. AU - Cao, Y. AU - Wang, S. PY - 2019 DA - 2019// TI - C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF/c-met signaling pathway JO - Cancer Biol Ther VL - 20 UR - https://doi.org/10.1080/15384047.2019.1647051 DO - 10.1080/15384047.2019.1647051 ID - Zhao2019 ER - TY - JOUR AU - Li, F. AU - Li, X. AU - Qiao, L. AU - Liu, W. AU - Xu, C. AU - Wang, X. PY - 2019 DA - 2019// TI - MALAT1 regulates miR-34a expression in melanoma cells JO - Cell Death Dis VL - 10 UR - https://doi.org/10.1038/s41419-019-1620-3 DO - 10.1038/s41419-019-1620-3 ID - Li2019 ER - TY - JOUR AU - Hlatky, L. AU - Olesiak, M. AU - Hahnfeldt, P. PY - 1996 DA - 1996// TI - Measurement of potential doubling time for human tumor xenografts using the cytokinesis-block method JO - Cancer Res VL - 56 ID - Hlatky1996 ER - TY - JOUR AU - Momen-Heravi, F. AU - Bala, S. AU - Kodys, K. AU - Szabo, G. PY - 2015 DA - 2015// TI - Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep09991 DO - 10.1038/srep09991 ID - Momen-Heravi2015 ER - TY - JOUR AU - Sun, X. AU - Huang, T. AU - Liu, Z. AU - Sun, M. AU - Luo, S. PY - 2019 DA - 2019// TI - LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway JO - Eur J Pharmacol VL - 856 UR - https://doi.org/10.1016/j.ejphar.2019.172407 DO - 10.1016/j.ejphar.2019.172407 ID - Sun2019 ER - TY - JOUR AU - Xin, X. AU - Lin, F. AU - Wang, Q. AU - Yin, L. AU - Mahato, R. I. PY - 2019 DA - 2019// TI - ROS-responsive polymeric micelles for triggered simultaneous delivery of PLK1 inhibitor/miR-34a and effective synergistic therapy in pancreatic Cancer JO - ACS Appl Mater Interfaces VL - 11 UR - https://doi.org/10.1021/acsami.9b02756 DO - 10.1021/acsami.9b02756 ID - Xin2019 ER - TY - JOUR AU - Subramanian, A. AU - Kuehn, H. AU - Gould, J. AU - Tamayo, P. AU - Mesirov, J. P. PY - 2007 DA - 2007// TI - GSEA-P: a desktop application for gene set enrichment analysis JO - Bioinformatics (Oxford, England) VL - 23 UR - https://doi.org/10.1093/bioinformatics/btm369 DO - 10.1093/bioinformatics/btm369 ID - Subramanian2007 ER - TY - JOUR AU - Li, X. J. AU - Ren, Z. J. AU - Tang, J. H. PY - 2014 DA - 2014// TI - MicroRNA-34a: a potential therapeutic target in human cancer JO - Cell Death Dis VL - 5 UR - https://doi.org/10.1038/cddis.2014.270 DO - 10.1038/cddis.2014.270 ID - Li2014 ER - TY - JOUR AU - Betel, D. AU - Wilson, M. AU - Gabow, A. AU - Marks, D. S. AU - Sander, C. PY - 2008 DA - 2008// TI - The microRNA.org resource: targets and expression JO - Nucleic Acids Res VL - 36 UR - https://doi.org/10.1093/nar/gkm995 DO - 10.1093/nar/gkm995 ID - Betel2008 ER - TY - JOUR AU - Guo, L. AU - Lu, Z. PY - 2010 DA - 2010// TI - The fate of miRNA* strand through evolutionary analysis: implication for degradation as merely carrier strand or potential regulatory molecule? JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0011387 DO - 10.1371/journal.pone.0011387 ID - Guo2010 ER - TY - JOUR AU - Wang, B. AU - Li, D. AU - Kovalchuk, I. AU - Apel, I. J. AU - Chinnaiyan, A. M. AU - Woycicki, R. K. AU - Cantor, C. R. AU - Kovalchuk, O. PY - 2018 DA - 2018// TI - miR-34a directly targets tRNAi (met) precursors and affects cellular proliferation, cell cycle, and apoptosis JO - Proc Natl Acad Sci U S A VL - 115 UR - https://doi.org/10.1073/pnas.1703029115 DO - 10.1073/pnas.1703029115 ID - Wang2018 ER - TY - STD TI - Cortez MA, Ivan C, Valdecanas D, Wang X, Peltier HJ, Ye Y, Araujo L, Carbone DP, Shilo K, Giri DK, et al. PDL1 regulation by p53 via miR-34. J Natl Cancer Inst. 2015;17:108(1). ID - ref44 ER - TY - JOUR AU - Metheetrairut, C. AU - Chotigavanich, C. AU - Amornpichetkul, K. AU - Keskool, P. AU - Ongard, S. AU - Metheetrairut, C. PY - 2019 DA - 2019// TI - Expression levels of miR-34-family microRNAs are associated with TP53 mutation status in head and neck squamous cell carcinoma JO - Eur Arch Otorhinolaryngol VL - 276 UR - https://doi.org/10.1007/s00405-018-5223-x DO - 10.1007/s00405-018-5223-x ID - Metheetrairut2019 ER - TY - JOUR AU - Momen-Heravi, F. AU - Bala, S. PY - 2018 DA - 2018// TI - Emerging role of non-coding RNA in oral cancer JO - Cell Signal VL - 42 UR - https://doi.org/10.1016/j.cellsig.2017.10.009 DO - 10.1016/j.cellsig.2017.10.009 ID - Momen-Heravi2018 ER - TY - JOUR AU - Ganci, F. AU - Sacconi, A. AU - Manciocco, V. AU - Covello, R. AU - Benevolo, M. AU - Rollo, F. AU - Strano, S. AU - Valsoni, S. AU - Bicciato, S. AU - Spriano, G. PY - 2017 DA - 2017// TI - Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence JO - Mod Pathol VL - 30 UR - https://doi.org/10.1038/modpathol.2017.62 DO - 10.1038/modpathol.2017.62 ID - Ganci2017 ER - TY - JOUR AU - Cristaldi, M. AU - Mauceri, R. AU - Fede, O. AU - Giuliana, G. AU - Campisi, G. AU - Panzarella, V. PY - 2019 DA - 2019// TI - Salivary biomarkers for Oral squamous cell carcinoma diagnosis and follow-up: current status and perspectives JO - Front Physiol VL - 10 UR - https://doi.org/10.3389/fphys.2019.01476 DO - 10.3389/fphys.2019.01476 ID - Cristaldi2019 ER - TY - JOUR AU - Rock, L. D. AU - Minatel, B. C. AU - Marshall, E. A. AU - Guisier, F. AU - Sage, A. P. AU - Barros-Filho, M. C. AU - Stewart, G. L. AU - Garnis, C. AU - Lam, W. L. PY - 2019 DA - 2019// TI - Expanding the Transcriptome of head and neck squamous cell carcinoma through novel MicroRNA discovery JO - Front Oncol VL - 9 UR - https://doi.org/10.3389/fonc.2019.01305 DO - 10.3389/fonc.2019.01305 ID - Rock2019 ER - TY - JOUR AU - Fadhil, R. S. AU - Wei, M. Q. AU - Nikolarakos, D. AU - Good, D. AU - Nair, R. G. PY - 2020 DA - 2020// TI - Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma JO - PLoS One VL - 15 UR - https://doi.org/10.1371/journal.pone.0221779 DO - 10.1371/journal.pone.0221779 ID - Fadhil2020 ER - TY - JOUR AU - Noguchi, T. AU - Ward, J. P. AU - Gubin, M. M. AU - Arthur, C. D. AU - Lee, S. H. AU - Hundal, J. AU - Selby, M. J. AU - Graziano, R. F. AU - Mardis, E. R. AU - Korman, A. J. PY - 2017 DA - 2017// TI - Temporally distinct PD-L1 expression by tumor and host cells contributes to immune escape JO - Cancer immunology research VL - 5 UR - https://doi.org/10.1158/2326-6066.CIR-16-0391 DO - 10.1158/2326-6066.CIR-16-0391 ID - Noguchi2017 ER - TY - JOUR AU - Bordon, Y. PY - 2019 DA - 2019// TI - Pro-tumour programming at the macrophage membrane JO - Nat Rev Immunol VL - 19 ID - Bordon2019 ER - TY - JOUR AU - Bao, Y. AU - Lu, Y. AU - Feng, W. AU - Yu, H. AU - Guo, H. AU - Tao, Y. AU - Shi, Q. AU - Chen, W. AU - Wang, X. PY - 2019 DA - 2019// TI - COUPTFII promotes epithelialmesenchymal transition by inhibiting miR34a expression in colorectal cancer JO - Int J Oncol VL - 54 ID - Bao2019 ER - TY - JOUR AU - Kapadia, C. H. AU - Ioele, S. A. AU - Day, E. S. PY - 2020 DA - 2020// TI - Layer-by-layer assembled PLGA nanoparticles carrying miR-34a cargo inhibit the proliferation and cell cycle progression of triple-negative breast cancer cells JO - J Biomed Mater Res A VL - 108 UR - https://doi.org/10.1002/jbm.a.36840 DO - 10.1002/jbm.a.36840 ID - Kapadia2020 ER - TY - JOUR AU - Li, Y. AU - Hu, H. AU - Wang, Y. AU - Fan, Y. AU - Yang, Y. AU - Guo, B. AU - Xie, X. AU - Lian, J. AU - Jiang, B. AU - Han, B. PY - 2020 DA - 2020// TI - CUL4B contributes to cancer stemness by repressing tumor suppressor miR34a in colorectal cancer JO - Oncogenesis VL - 9 UR - https://doi.org/10.1038/s41389-020-0206-3 DO - 10.1038/s41389-020-0206-3 ID - Li2020 ER - TY - JOUR AU - Oner, M. G. AU - Rokavec, M. AU - Kaller, M. AU - Bouznad, N. AU - Horst, D. AU - Kirchner, T. AU - Hermeking, H. PY - 2018 DA - 2018// TI - Combined inactivation of TP53 and MIR34A promotes colorectal Cancer development and progression in mice via increasing levels of IL6R and PAI1 JO - Gastroenterology VL - 155 UR - https://doi.org/10.1053/j.gastro.2018.08.011 DO - 10.1053/j.gastro.2018.08.011 ID - Oner2018 ER - TY - JOUR AU - Li, Q. AU - Wang, C. AU - Cai, L. AU - Lu, J. AU - Zhu, Z. AU - Wang, C. AU - Su, Z. AU - Lu, X. PY - 2019 DA - 2019// TI - miR34a derived from mesenchymal stem cells stimulates senescence in glioma cells by inducing DNA damage JO - Mol Med Rep VL - 19 ID - Li2019 ER - TY - JOUR AU - Yang, G. AU - Fu, Y. AU - Lu, X. AU - Wang, M. AU - Dong, H. AU - Li, Q. PY - 2019 DA - 2019// TI - miR34a regulates the chemosensitivity of retinoblastoma cells via modulation of MAGEA/p53 signaling JO - Int J Oncol VL - 54 ID - Yang2019 ER - TY - JOUR AU - Wei, B. AU - Huang, Q. Y. AU - Huang, S. R. AU - Mai, W. AU - Zhong, X. G. PY - 2015 DA - 2015// TI - MicroRNA34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET JO - Mol Med Rep VL - 12 UR - https://doi.org/10.3892/mmr.2015.4110 DO - 10.3892/mmr.2015.4110 ID - Wei2015 ER - TY - JOUR AU - Parsons, B. M. AU - Meier, D. R. AU - Richmond, C. S. AU - Gurda, G. T. AU - Lofgren, K. A. AU - Burkard, M. E. AU - Deming, D. A. AU - Kenny, P. A. PY - 2020 DA - 2020// TI - Acquisition of Cabozantinib-sensitive MET D1228N mutation during progression on Crizotinib in MET-amplified triple-negative breast Cancer JO - Clin Breast Cancer VL - 20 UR - https://doi.org/10.1016/j.clbc.2020.02.003 DO - 10.1016/j.clbc.2020.02.003 ID - Parsons2020 ER - TY - JOUR AU - Li, N. AU - Fu, H. AU - Tie, Y. AU - Hu, Z. AU - Kong, W. AU - Wu, Y. AU - Zheng, X. PY - 2009 DA - 2009// TI - miR-34a inhibits migration and invasion by down-regulation of c-met expression in human hepatocellular carcinoma cells JO - Cancer Lett VL - 275 UR - https://doi.org/10.1016/j.canlet.2008.09.035 DO - 10.1016/j.canlet.2008.09.035 ID - Li2009 ER - TY - JOUR AU - Li, P. AU - Zhang, J. AU - Li, F. AU - Yu, Y. AU - Chen, Y. PY - 2019 DA - 2019// TI - Lowintensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR34a/cMet axis JO - Int J Mol Med VL - 44 ID - Li2019 ER - TY - JOUR AU - Schuler, M. AU - Berardi, R. AU - Lim, W. T. AU - Jonge, M. AU - Bauer, T. M. AU - Azaro, A. AU - Gottfried, M. AU - Han, J. Y. AU - Lee, D. H. AU - Wollner, M. PY - 2020 DA - 2020// TI - Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial JO - Ann Oncol. VL - 31 UR - https://doi.org/10.1016/j.annonc.2020.03.293 DO - 10.1016/j.annonc.2020.03.293 ID - Schuler2020 ER - TY - JOUR AU - Shimokawa, M. AU - Nosaki, K. AU - Seto, T. AU - Ohashi, K. AU - Morise, M. AU - Horinouchi, H. AU - Sakakibara, J. AU - Murakami, H. AU - Yano, S. AU - Satouchi, M. PY - 2020 DA - 2020// TI - Phase II, open-label, multicenter trial of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: co-MET study JO - Trials VL - 21 UR - https://doi.org/10.1186/s13063-020-4221-7 DO - 10.1186/s13063-020-4221-7 ID - Shimokawa2020 ER - TY - JOUR AU - Gherardi, E. AU - Birchmeier, W. AU - Birchmeier, C. AU - Vande Woude, G. PY - 2012 DA - 2012// TI - Targeting MET in cancer: rationale and progress JO - Nat Rev Cancer VL - 12 UR - https://doi.org/10.1038/nrc3205 DO - 10.1038/nrc3205 ID - Gherardi2012 ER - TY - JOUR AU - Li, H. AU - Li, C. W. AU - Li, X. AU - Ding, Q. AU - Guo, L. AU - Liu, S. AU - Liu, C. AU - Lai, C. C. AU - Hsu, J. M. AU - Dong, Q. PY - 2019 DA - 2019// TI - MET inhibitors promote liver tumor evasion of the immune response by stabilizing PDL1 JO - Gastroenterology VL - 156 ID - Li2019 ER - TY - JOUR AU - Li, Q. AU - Hutchins, A. P. AU - Chen, Y. AU - Li, S. AU - Shan, Y. AU - Liao, B. AU - Zheng, D. AU - Shi, X. AU - Li, Y. AU - Chan, W. Y. PY - 2017 DA - 2017// TI - A sequential EMT-MET mechanism drives the differentiation of human embryonic stem cells towards hepatocytes JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/ncomms15166 DO - 10.1038/ncomms15166 ID - Li2017 ER - TY - JOUR AU - Hartmann, S. AU - Bhola, N. E. AU - Grandis, J. R. PY - 2016 DA - 2016// TI - HGF/met signaling in head and neck Cancer: impact on the tumor microenvironment JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-16-0951 DO - 10.1158/1078-0432.CCR-16-0951 ID - Hartmann2016 ER - TY - JOUR AU - Krumbach, R. AU - Schuler, J. AU - Hofmann, M. AU - Giesemann, T. AU - Fiebig, H. H. AU - Beckers, T. PY - 2011 DA - 2011// TI - Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistance JO - Eur J Cancer VL - 47 UR - https://doi.org/10.1016/j.ejca.2010.12.019 DO - 10.1016/j.ejca.2010.12.019 ID - Krumbach2011 ER - TY - JOUR AU - Seiwert, T. Y. AU - Jagadeeswaran, R. AU - Faoro, L. AU - Janamanchi, V. AU - Nallasura, V. AU - Dinali, M. AU - Yala, S. AU - Kanteti, R. AU - Cohen, E. E. AU - Lingen, M. W. PY - 2009 DA - 2009// TI - The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-2881 DO - 10.1158/0008-5472.CAN-08-2881 ID - Seiwert2009 ER - TY - JOUR AU - Novoplansky, O. AU - Fury, M. AU - Prasad, M. AU - Yegodayev, K. AU - Zorea, J. AU - Cohen, L. AU - Pelossof, R. AU - Cohen, L. AU - Katabi, N. AU - Cecchi, F. PY - 2019 DA - 2019// TI - MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer JO - Int J Cancer VL - 145 UR - https://doi.org/10.1002/ijc.32170 DO - 10.1002/ijc.32170 ID - Novoplansky2019 ER - TY - JOUR AU - Daassi, D. AU - Mahoney, K. M. AU - Freeman, G. J. PY - 2020 DA - 2020// TI - The importance of exosomal PDL1 in tumour immune evasion JO - Nat Rev Immunol VL - 20 UR - https://doi.org/10.1038/s41577-019-0264-y DO - 10.1038/s41577-019-0264-y ID - Daassi2020 ER - TY - JOUR AU - Mahoney, K. M. AU - Rennert, P. D. AU - Freeman, G. J. PY - 2015 DA - 2015// TI - Combination cancer immunotherapy and new immunomodulatory targets JO - Nat Rev Drug Discov VL - 14 UR - https://doi.org/10.1038/nrd4591 DO - 10.1038/nrd4591 ID - Mahoney2015 ER - TY - JOUR AU - Lin, H. AU - Wei, S. AU - Hurt, E. M. AU - Green, M. D. AU - Zhao, L. AU - Vatan, L. AU - Szeliga, W. AU - Herbst, R. AU - Harms, P. W. AU - Fecher, L. A. PY - 2018 DA - 2018// TI - Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression JO - J Clin Invest VL - 128 UR - https://doi.org/10.1172/JCI120803 DO - 10.1172/JCI120803 ID - Lin2018 ER - TY - JOUR AU - Tseng, Y. H. AU - Ho, H. L. AU - Lai, C. R. AU - Luo, Y. H. AU - Tseng, Y. C. AU - Whang-Peng, J. AU - Lin, Y. H. AU - Chou, T. Y. AU - Chen, Y. M. PY - 2018 DA - 2018// TI - PD-L1 expression of tumor cells, macrophages, and immune cells in non-small cell lung Cancer patients with malignant pleural effusion JO - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer VL - 13 UR - https://doi.org/10.1016/j.jtho.2017.10.034 DO - 10.1016/j.jtho.2017.10.034 ID - Tseng2018 ER - TY - JOUR AU - Liu, Y. AU - Zugazagoitia, J. AU - Ahmed, F. S. AU - Henick, B. S. AU - Gettinger, S. N. AU - Herbst, R. S. AU - Schalper, K. A. AU - Rimm, D. L. PY - 2020 DA - 2020// TI - Immune cell PD-L1 Colocalizes with macrophages and is associated with outcome in PD-1 pathway blockade therapy JO - Clinical cancer research : an official journal of the American Association for Cancer Research VL - 26 UR - https://doi.org/10.1158/1078-0432.CCR-19-1040 DO - 10.1158/1078-0432.CCR-19-1040 ID - Liu2020 ER - TY - JOUR AU - Rose, M. AU - Duhamel, M. AU - Aboulouard, S. AU - Kobeissy, F. AU - Rhun, E. AU - Desmons, A. AU - Tierny, D. AU - Fournier, I. AU - Rodet, F. AU - Salzet, M. PY - 2020 DA - 2020// TI - The role of a Proprotein Convertase inhibitor in reactivation of tumor-associated macrophages and inhibition of Glioma growth JO - Molecular therapy oncolytics VL - 17 UR - https://doi.org/10.1016/j.omto.2020.03.005 DO - 10.1016/j.omto.2020.03.005 ID - Rose2020 ER - TY - JOUR AU - Latchman, Y. E. AU - Liang, S. C. AU - Wu, Y. AU - Chernova, T. AU - Sobel, R. A. AU - Klemm, M. AU - Kuchroo, V. K. AU - Freeman, G. J. AU - Sharpe, A. H. PY - 2004 DA - 2004// TI - PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells JO - Proceedings of the National Academy of Sciences of the United States of America VL - 101 UR - https://doi.org/10.1073/pnas.0307252101 DO - 10.1073/pnas.0307252101 ID - Latchman2004 ER - TY - JOUR AU - Ding, Z. C. AU - Lu, X. AU - Yu, M. AU - Lemos, H. AU - Huang, L. AU - Chandler, P. AU - Liu, K. AU - Walters, M. AU - Krasinski, A. AU - Mack, M. PY - 2014 DA - 2014// TI - Immunosuppressive myeloid cells induced by chemotherapy attenuate antitumor CD4+ T-cell responses through the PD-1-PD-L1 axis JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-13-3596 DO - 10.1158/0008-5472.CAN-13-3596 ID - Ding2014 ER - TY - JOUR AU - Semple, S. C. AU - Harasym, T. O. AU - Clow, K. A. AU - Ansell, S. M. AU - Klimuk, S. K. AU - Hope, M. J. PY - 2005 DA - 2005// TI - Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid JO - J Pharmacol Exp Ther VL - 312 UR - https://doi.org/10.1124/jpet.104.078113 DO - 10.1124/jpet.104.078113 ID - Semple2005 ER - TY - JOUR AU - Momen-Heravi, F. AU - Getting, S. J. AU - Moschos, S. A. PY - 2018 DA - 2018// TI - Extracellular vesicles and their nucleic acids for biomarker discovery JO - Pharmacol Ther VL - 192 UR - https://doi.org/10.1016/j.pharmthera.2018.08.002 DO - 10.1016/j.pharmthera.2018.08.002 ID - Momen-Heravi2018 ER - TY - JOUR AU - Chen, Y. AU - Gao, D. Y. AU - Huang, L. PY - 2015 DA - 2015// TI - In vivo delivery of miRNAs for cancer therapy: challenges and strategies JO - Adv Drug Deliv Rev VL - 81 UR - https://doi.org/10.1016/j.addr.2014.05.009 DO - 10.1016/j.addr.2014.05.009 ID - Chen2015 ER -